Volltext verfügbar nach Anmeldung bzw. im Campus-Netz.
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
In: PR Newswire US, 2024-03-01
Online
Zeitungsartikel
Zugriff:
CAMBRIDGE, Mass., March 1, 2024 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options to purchase an aggregate of 4,000 shares of Akebia's common stock on February 29, 2024, as an inducement material to such employee entering into employment with Akebia. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4). [ABSTRACT FROM PUBLISHER]
Titel: |
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
---|---|
Autor/in / Beteiligte Person: | Newswire, PR |
Zeitschrift: | PR Newswire US, 2024-03-01 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|